Nemaura Medical Inc
NASDAQ:NMRD 10:43:57 AM EDT
| Market Cap (Intraday) | 10.40M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.38 |
| 50-Day MA | $0.63 |
| 200-Day MA | $0.98 |
Nemaura Medical Inc Stock, NASDAQ:NMRD
57 West 57th Street, Manhattan, New York, New York 10019
United States of America
Phone: +1.646.416.8000
Number of Employees: 38
Description
Nemaura Medical, Inc. operates as a holding company. The firm engages in the provision of medical device research. It manufactures and commercializes glucose monitoring system, named sugarBEAT. The sugarBEAT consists of a disposable adhesive skin-patch connected to a rechargeable wireless transmitter that displays glucose readings at regular five minute intervals with the use of a mobile app. The company was founded by Dewan Fazlul Hoque Chowdhury on December 24, 2013 and is headquartered in New York, NY.